Effects of nicotinic acid on poloxamer 407-induced hyperlipidemia

Pharmacotherapy

Volumn 16, Issue 1 I, 1996, Pages 10-15

  Nash, Virginia J ^a   Johnston, Thomas P ^a   Palmer, Warren K ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC ACID; POLOXAMER;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY RISK; DRUG EFFECT; FATTY ACID TRANSPORT; HYPERLIPIDEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; DRUG COMBINATIONS; FASTING; HYPERLIPIDEMIAS; INJECTIONS, INTRAPERITONEAL; MALE; NIACIN; POLOXALENE; RATS; RATS, WISTAR; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES;

EID: 0030022612     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Shepherd J, Packard CJ. Pharmacological approaches to the modulation of plasma cholesterol Trends Pharmacol Sci 1988;9:326-9
2. Wilkund O, Angelin B, Bergman M, et al. Pravastatin and gemfibrozil alone or in combination for the treatment of hypercholesterolemia. Am J Med 1993;94:13-20.
3. White RA. Atherosclerosis and arteriosclerosis. In: White RA, ed. Human pathology and experimental animal methods. Boca Raton, FL CRC Press, 1989:171-7
4. Rapacz J, Hasler-Rapacz J. Animal models: the pig. In: Lusis AJ, Sparkes SR, eds. Genetic factors in atherosclerosis: approaches and model systems. Basel: Karger, 1989:139-69
5. Schurr PE, Schultz JR, Parkinson TM. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs Lipids 1971;7:68-74.
6. Okazaki M, Suzuki M, Oguchi K. Changes in coagulative and fibrinolytic activities in Triton WR-1339-induced hyperlipidemia in rats. Jpn J Pharmacol. 1990;52:353-61.
7. Wout ZGM, Pec EA, Maggiore JA, Williams RH, Parlicharla P, Johnston TP. Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats. J Parenter Sci Technol 1992;46:192-200.
8. Johnston TP, Palmer WK. Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat Biochem Pharmacol 1993;46:1037-42.
9. Porter JA, Carter BL, Johnston TP, Palmer WK. Effects of pravastatin on plasma lipid concentrations in poloxamer 407-induced hyperlipidemic rats. Pharmacotherapy 1995;15:92-8.
10. Bergstrom J, Hultman E, Jorfeldt L, Pernow B, Wahren J Effect of nicotinic acid on physical working capacity and on metabolism of muscle glycogen in man J Appl Physiol 1969;26:170-6
11. Datta S, Das DK, Engleman RM, et al. Enhanced myocardial preservation by nicotinic acid and antilipolytic compound, mechanism of action. Basic Res Cardiol 1989;84:63-76.
12. Drood, JM, Zimetbaum PJ, Frishman WH. Nicotinic acid for the treatment of hyperlipoproteinemia. J Clin Pharmacol 1991;31:641-50.
13. Holland RE, Rahman K, Morris AI, Coleman R, Billington D. Effects of niacin on biliary lipid output in the rat. Biochem Pharmacol 1993;45:43-9.
14. Illingworth DR. Lipid-lowering drugs. Drugs 1987;33:259-79.
15. Wahlberg G, Waldius G. Effect of nicotinic acid treatment on fatty acid composition of plasma lipids and adipose tissue in hyperlipidemia Scand J Clin Lab Invest 1992;52:547-53
16. Carlson LA, Froberg SO, Nye ER. Acute effects of nicotinic acid on plasma liver, heart, and muscle lipids II, Nicotinic acid m the rat. Acta Med Scand 1966;180:571-9
17. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19: 476-82.
18. Allain CA, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
19. Gibaldi M, Perrier D Estimation of areas. In: Gibaldi M, Perrier D, eds. Pharmacokinetics. New York: Marcel Dekker, 1982:445-9.
20. Steel RGD, Torrie JH. Principles and procedures of statistics. New York: McGraw-Hill, 1960:99-131
21. LaDu MJ, Kapsas H, Palmer WK. Regulation of lipoprotein lipase in adipose and muscle tissues during fasting Am J Physiol 1991;260:R953-9.
22. Carlson LA, Nye ER. Acute affects of nicotinic acid in the rat. I. Plasma and liver lipids and blood glucose. Acta Med Scand 1966;179:453-61.